Intrabio Drug Patent Portfolio

Intrabio owns 1 orange book drug protected by 3 US patents Given below is the list of Intrabio's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11400067 Pharmaceutical compositions and uses directed to lysosomal storage disorders 19 Apr, 2037
Active
US12433862 Pharmaceutical Compositions And Uses Directed To Lysosomal Storage Disorders 19 Apr, 2037
Active
US12433863 Pharmaceutical Compositions And Uses Directed To Lysosomal Storage Disorders 19 Apr, 2037
Active


Given below is the list of recent legal activities going on the following drug patents of Intrabio.

Activity Date Patent Number
Patent litigations
Dispatch to FDC 13 Aug, 2025 US12433863
Application Is Considered Ready for Issue 13 Aug, 2025 US12433863
Dispatch to FDC 07 Aug, 2025 US12433862
Application Is Considered Ready for Issue 07 Aug, 2025 US12433862
Issue Fee Payment Verified 06 Aug, 2025 US12433862
Issue Fee Payment Received 06 Aug, 2025 US12433863
Issue Fee Payment Received 06 Aug, 2025 US12433862
Issue Fee Payment Verified 06 Aug, 2025 US12433863
Mail Notice of Allowance 29 Jul, 2025 US12433863
Mail Notice of Allowance 29 Jul, 2025 US12433862
Affidavit(s) (Rule 131 or 132) or Exhibit(s) Received 28 Jul, 2025 US12433863
Notice of Allowance Data Verification Completed 28 Jul, 2025 US12433862
Notice of Allowance Data Verification Completed 27 Jul, 2025 US12433863
Interview Summary - Examiner Initiated - Telephonic 18 Jul, 2025 US12433862
Interview Summary - Examiner Initiated - Telephonic 18 Jul, 2025 US12433863


Intrabio's Family Patents


Family Patents



Intrabio Drug List

Given below is the complete list of Intrabio's drugs and the patents protecting them.


1. Aqneursa

Aqneursa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11400067 Pharmaceutical compositions and uses directed to lysosomal storage disorders 19 Apr, 2037
(11 years from now)
Active
US12433862 Pharmaceutical Compositions And Uses Directed To Lysosomal Storage Disorders 19 Apr, 2037
(11 years from now)
Active
US12433863 Pharmaceutical Compositions And Uses Directed To Lysosomal Storage Disorders 19 Apr, 2037
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aqneursa's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List